|
1
|
Katsura C, Ogunmwonyi I, Kankam HK and
Saha S: Breast cancer: Presentation, investigation and management.
Br J Hosp Med (Lond). 83:1–7. 2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Bose S and Le A: Glucose metabolism in
cancer. Adv Exp Med Biol. 1063:3–12. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Shiraishi T, Verdone JE, Huang J, Kahlert
UD, Hernandez JR, Torga G, Zarif JC, Epstein T, Gatenby R,
McCartney A, et al: Glycolysis is the primary bioenergetic pathway
for cell motility and cytoskeletal remodeling in human prostate and
breast cancer cells. Oncotarget. 6:130–143. 2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wu Z, Wu J, Zhao Q, Fu S and Jin J:
Emerging roles of aerobic glycolysis in breast cancer. Clin Transl
Oncol. 22:631–646. 2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Krumlauf R: Hox genes, clusters and
collinearity. Int J Dev Biol. 62:659–663. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ishii Y, Taguchi A and Kukimoto I: The
homeobox transcription factor HOXC13 upregulates human
papillomavirus E1 gene expression and contributes to viral genome
maintenance. FEBS Lett. 594:751–762. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Li C, Cui J, Zou L, Zhu L and Wei W:
Bioinformatics analysis of the expression of HOXC13 and its role in
the prognosis of breast cancer. Oncol Lett. 19:899–907.
2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Luo J, Wang Z, Huang J, Yao Y, Sun Q, Wang
J, Shen Y, Xu L and Ren B: HOXC13 promotes proliferation of
esophageal squamous cell carcinoma via repressing transcription of
CASP3. Cancer Sci. 109:317–329. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Liu B, Li J, Li JM, Liu GY and Wang YS:
HOXC-AS2 mediates the proliferation, apoptosis, and migration of
non-small cell lung cancer by combining with HOXC13 gene. Cell
Cycle. 20:236–246. 2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Dai M, Song J, Wang L, Zhou K and Shu L:
HOXC13 promotes cervical cancer proliferation, invasion and Warburg
effect through β-catenin/c-Myc signaling pathway. J Bioenerg
Biomembr. 53:597–608. 2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Okano M, Bell DW, Haber DA and Li E: DNA
methyltransferases Dnmt3a and Dnmt3b are essential for de novo
methylation and mammalian development. Cell. 99:247–257.
1999.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yang X, Han H, De Carvalho DD, Lay FD,
Jones PA and Liang G: Gene body methylation can alter gene
expression and is a therapeutic target in cancer. Cancer Cell.
26:577–590. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lu J, Zhen S, Tuo X, Chang S, Yang X, Zhou
Y, Chen W, Zhao L and Li X: Downregulation of DNMT3A attenuates the
warburg effect, proliferation, and invasion via promoting the
inhibition of miR-603 on HK2 in ovarian cancer. Technol Cancer Res
Treat. 21(15330338221110668)2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zhou Y, Yang Z, Zhang H, Li H, Zhang M,
Wang H, Zhang M, Qiu P, Zhang R and Liu J: DNMT3A facilitates
colorectal cancer progression via regulating DAB2IP mediated
MEK/ERK activation. Biochim Biophys Acta Mol Basis Dis.
1868(166353)2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Li Y, Jiang B, He Z, Zhu H, He R, Fan S,
Wu X, Xie L and He X: circIQCH sponges miR-145 to promote breast
cancer progression by upregulating DNMT3A expression. Aging (Albany
NY). 12:15532–15545. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A portal for facilitating tumor subgroup gene
expression and survival analyses. Neoplasia. 19:649–658.
2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Fornes O, Castro-Mondragon JA, Khan A, van
der Lee R, Zhang X, Richmond PA, Modi BP, Correard S, Gheorghe M,
Baranasic D, et al: JASPAR 2020: Update of the open-access database
of transcription factor binding profiles. Nucleic Acids Res.
48(D1):D87–D92. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Wang S, Li F, Liu J, Zhang Y, Zheng Y, Ge
W, Qu L and Wang X: Integrative analysis of methylome and
transcriptome reveals the regulatory mechanisms of hair follicle
morphogenesis in Cashmere Goat. Cells. 9(969)2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Fernandez-Guerrero M, Yakushiji-Kaminatsui
N, Lopez-Delisle L, Zdral S, Darbellay F, Perez-Gomez R, Bolt CC,
Sanchez-Martin MA, Duboule D and Ros MA: Mammalian-specific
ectodermal enhancers control the expression of Hoxc genes in
developing nails and hair follicles. Proc Natl Acad Sci USA.
117:30509–30519. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Li J, Zhang B, Wang B and Zhang X: LncRNA
HOXC-AS5 affects the proliferation, invasion and cell cycle of
ameloblastoma cells by acting on the target gene HOXC13. Cell Mol
Biol (Noisy-le-grand). 68:124–134. 2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Hong YS, Wang J, Liu J, Zhang B, Hou L and
Zhong M: Expression of HOX C13 in odontogenic tumors. Shanghai Kou
Qiang Yi Xue. 16:587–591. 2007.PubMed/NCBI(In Chinese).
|
|
25
|
Cantile M, Scognamiglio G, Anniciello A,
Farina M, Gentilcore G, Santonastaso C, Fulciniti F, Cillo C,
Franco R, Ascierto PA and Botti G: Increased HOX C13 expression in
metastatic melanoma progression. J Transl Med.
10(91)2012.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Cantile M, Galletta F, Franco R, Aquino G,
Scognamiglio G, Marra L, Cerrone M, Malzone G, Manna A, Apice G, et
al: Hyperexpression of HOXC13, located in the 12q13 chromosomal
region, in well-differentiated and dedifferentiated human
liposarcomas. Oncol Rep. 30:2579–2586. 2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zhou Y, Zheng X, Lu J, Chen W, Li X and
Zhao L: Ginsenoside 20(S)-Rg3 inhibits the warburg effect via
modulating DNMT3A/MiR-532-3p/HK2 pathway in ovarian cancer cells.
Cell Physiol Biochem. 45:2548–2559. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yu M, Al-Dallal S, Al-Haj L, Panjwani S,
McCartney AS, Edwards SM, Manjunath P, Walker C, Awgulewitsch A and
Hentges KE: Transcriptional regulation of the proto-oncogene Zfp521
by SPI1 (PU.1) and HOXC13. Genesis. 54:519–533. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Yao Y, Luo J, Sun Q, Xu T, Sun S, Chen M,
Lin X, Qian Q, Zhang Y, Cao L, et al: HOXC13 promotes proliferation
of lung adenocarcinoma via modulation of CCND1 and CCNE1. Am J
Cancer Res. 71820–1834. (eCollection 2017)2017.PubMed/NCBI
|
|
30
|
Liu Z, Zhang L, Chen W, Yuan F, Yang Z,
Liu S and Le F: miR-195-5p regulates cell proliferation, apoptosis,
and invasion of thyroid cancer by targeting telomerase reverse
transcriptase. Bioengineered. 12:6201–6209. 2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Fan C, Wang Q, van der Zon G, Ren J,
Agaser C, Slieker RC, Iyengar PV, Mei H and Ten Dijke P: OVOL1
inhibits breast cancer cell invasion by enhancing the degradation
of TGF-β type I receptor. Signal Transduct Target Ther.
7(126)2022.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Fu Y, Zhang X, Liu X, Wang P, Chu W, Zhao
W, Wang Y, Zhou G, Yu Y and Zhang H: The DNMT1-PAS1-PH20 axis
drives breast cancer growth and metastasis. Signal Transduct Target
Ther. 7(81)2022.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Abbaszadeh Z, Cesmeli S and Biray Avci C:
Crucial players in glycolysis: Cancer progress. Gene.
726(144158)2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Abdel-Wahab AF, Mahmoud W and Al-Harizy
RM: Targeting glucose metabolism to suppress cancer progression:
Prospective of anti-glycolytic cancer therapy. Pharmacol Res.
150(104511)2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Lambert M, Jambon S, Depauw S and
David-Cordonnier MH: Targeting transcription factors for cancer
treatment. Molecules. 23(1479)2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Na F, Pan X, Chen J, Chen X, Wang M, Chi
P, You L, Zhang L, Zhong A, Zhao L, et al: KMT2C deficiency
promotes small cell lung cancer metastasis through DNMT3A-mediated
epigenetic reprogramming. Nat Cancer. 3:753–767. 2022.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Mancini M, Grasso M, Muccillo L, Babbio F,
Precazzini F, Castiglioni I, Zanetti V, Rizzo F, Pistore C, De
Marino MG, et al: DNMT3A epigenetically regulates key microRNAs
involved in epithelial-to-mesenchymal transition in prostate
cancer. Carcinogenesis. 42:1449–1460. 2021.PubMed/NCBI View Article : Google Scholar
|
